This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsAgatos (5JS1) 주식 개요Operates as an engineering, procurement, and construction company in Italy. 자세히 보기5JS1 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장5/6과거 실적0/6재무 건전성0/6배당0/6강점수익은 매년 129.43% 증가할 것으로 예상됩니다.위험 분석의미 있는 시가총액이 없습니다(€5M)마이너스 주주 지분지난 1년 동안 주주가 크게 희석되었습니다.주식은 유동성이 매우 낮습니다모든 위험 점검 보기5JS1 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.2290.8% 저평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-13m101m2016201920222025202620282031Revenue €101.1mEarnings €5.5mAdvancedSet Fair ValueView all narrativesAgatos S.p.A. 경쟁사AHT Syngas TechnologySymbol: DB:3SQ1Market cap: €6.2mPittler MaschinenfabrikSymbol: DB:PITMarket cap: €4.0mBAUERSymbol: HMSE:B5A0Market cap: €258.2mCompleo Charging SolutionsSymbol: XTRA:C0MMarket cap: €14.3m가격 이력 및 성과Agatos 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가€0.2252주 최고가€0.7152주 최저가€0.16베타1.131개월 변동0%3개월 변동-2.22%1년 변동-58.96%3년 변동-78.11%5년 변동n/aIPO 이후 변동-80.87%최근 뉴스 및 업데이트New Risk • Jul 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-€3.4m). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Market cap is less than US$10m (€8.25m market cap, or US$9.18m). Minor Risk Less than 1 year of cash runway based on current free cash flow (-€7.9m).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Sep 24Agatos S.p.A. announced that it expects to receive €10 million in funding from Macquarie Group Limited, Investment Arm and other investorAgatos S.p.A. announced a private placement of convertible bonds for gross proceeds of up to €10,000,000 on September 22, 2022. The transaction will include participation from Macquarie Group Limited, Investment Arm, and ATLAS CAPITAL. The company has approved partial issuance of first tranche of convertible bond for up to €1,500,000.Reported Earnings • Jun 18Full year 2021 earnings releasedFull year 2021 results: Net loss: €13.2m (loss widened 247% from FY 2020).Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Oct 06First half 2021 earnings releasedThe company reported a soft first half result with increased losses and weaker control over costs, although revenues improved. First half 2021 results: Revenue: €1.93m (up 17% from 1H 2020). Net loss: €6.82m (loss widened 366% from 1H 2020).더 많은 업데이트 보기Recent updatesNew Risk • Jul 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-€3.4m). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Market cap is less than US$10m (€8.25m market cap, or US$9.18m). Minor Risk Less than 1 year of cash runway based on current free cash flow (-€7.9m).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Sep 24Agatos S.p.A. announced that it expects to receive €10 million in funding from Macquarie Group Limited, Investment Arm and other investorAgatos S.p.A. announced a private placement of convertible bonds for gross proceeds of up to €10,000,000 on September 22, 2022. The transaction will include participation from Macquarie Group Limited, Investment Arm, and ATLAS CAPITAL. The company has approved partial issuance of first tranche of convertible bond for up to €1,500,000.Reported Earnings • Jun 18Full year 2021 earnings releasedFull year 2021 results: Net loss: €13.2m (loss widened 247% from FY 2020).Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Oct 06First half 2021 earnings releasedThe company reported a soft first half result with increased losses and weaker control over costs, although revenues improved. First half 2021 results: Revenue: €1.93m (up 17% from 1H 2020). Net loss: €6.82m (loss widened 366% from 1H 2020).Breakeven Date Change • Sep 23Forecast to breakeven in 2022The analyst covering Agatos expects the company to break even for the first time. New forecast suggests the company will make a profit of €1.72m in 2022. Average annual earnings growth of 99% is required to achieve expected profit on schedule.공시 • Dec 30Sorgenia Sviluppo S.R.L. completed the acquisition of 75% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. (BIT:AGA) for €3.1 million.Sorgenia Sviluppo S.R.L. made a binding offer to acquire 80% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. (BIT:AGA) for €2.2 million on October 10, 2019. On December 17, 2020, Sorgenia Sviluppo S.R.L. signed agreement to acquire 75% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. Under the terms, the buyer will pay up to €0.2 million and will take up to 80% of Agatos's claims towards the project for up to €2 million. As of April 21, 2020, Agatos said that more time is needed to complete the transaction amid COVID-19 crisis. As of July 8, 2020, Agatos S.p.A. postpone the final terms of the deal to August 7, 2020. Closing is expected by year end 2020. Sorgenia Sviluppo S.R.L. completed the acquisition of 75% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. (BIT:AGA) for €3.1 million on December 28, 2020. The consideration includes €0.15 for Green Power Marcallese, €0.6 million for the debt owed by Green Power Marcallese to Agatos and assumed €2.3 million remaining creditor of Green Power Marcallese.Is New 90 Day High Low • Nov 28New 90-day high: €1.04The company is up 3.0% from its price of €1.01 on 28 August 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Construction industry, which is up 9.0% over the same period.Reported Earnings • Oct 04First half earnings releasedOver the last 12 months the company has reported total losses of €2.86m, with losses widening by 32% from the prior year. Total revenue was €3.84m over the last 12 months, down 41% from the prior year.주주 수익률5JS1DE ConstructionDE 시장7D0%-0.4%3.9%1Y-59.0%169.2%2.6%전체 주주 수익률 보기수익률 대 산업: 5JS1은 지난 1년 동안 169.2%의 수익을 기록한 German Construction 산업보다 저조한 성과를 냈습니다.수익률 대 시장: 5JS1은 지난 1년 동안 2.6%를 기록한 German 시장보다 저조한 성과를 냈습니다.주가 변동성Is 5JS1's price volatile compared to industry and market?5JS1 volatility5JS1 Average Weekly Movementn/aConstruction Industry Average Movement5.3%Market Average Movement6.1%10% most volatile stocks in DE Market12.9%10% least volatile stocks in DE Market2.7%안정적인 주가: 5JS1의 주가는 지난 3개월 동안 German 시장보다 변동성이 컸습니다.시간에 따른 변동성: Insufficient data to determine 5JS1의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트n/a23Massimo Mannoriwww.agatos.it더 보기Agatos S.p.A. 기초 지표 요약Agatos의 순이익과 매출은 시가총액과 어떻게 비교됩니까?5JS1 기초 통계시가총액€4.87m순이익 (TTM)-€3.68m매출 (TTM)€20.63m0.2x주가매출비율(P/S)-1.3x주가수익비율(P/E)5JS1는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표5JS1 손익계산서 (TTM)매출€20.63m매출원가€20.65m총이익-€23.58k기타 비용€3.66m순이익-€3.68m최근 보고된 실적Dec 31, 2022다음 실적 발표일해당 없음주당순이익(EPS)-0.18총이익률-0.11%순이익률-17.87%부채/자본 비율-500.9%5JS1의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/12/26 06:49종가2023/09/28 00:00수익2022/12/31연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Agatos S.p.A.는 2명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Arianna TerazziIntesa Sanpaolo Equity ResearchMarco CristoforiIntesa Sanpaolo Equity Research
New Risk • Jul 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-€3.4m). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Market cap is less than US$10m (€8.25m market cap, or US$9.18m). Minor Risk Less than 1 year of cash runway based on current free cash flow (-€7.9m).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Sep 24Agatos S.p.A. announced that it expects to receive €10 million in funding from Macquarie Group Limited, Investment Arm and other investorAgatos S.p.A. announced a private placement of convertible bonds for gross proceeds of up to €10,000,000 on September 22, 2022. The transaction will include participation from Macquarie Group Limited, Investment Arm, and ATLAS CAPITAL. The company has approved partial issuance of first tranche of convertible bond for up to €1,500,000.
Reported Earnings • Jun 18Full year 2021 earnings releasedFull year 2021 results: Net loss: €13.2m (loss widened 247% from FY 2020).
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 06First half 2021 earnings releasedThe company reported a soft first half result with increased losses and weaker control over costs, although revenues improved. First half 2021 results: Revenue: €1.93m (up 17% from 1H 2020). Net loss: €6.82m (loss widened 366% from 1H 2020).
New Risk • Jul 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-€3.4m). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Market cap is less than US$10m (€8.25m market cap, or US$9.18m). Minor Risk Less than 1 year of cash runway based on current free cash flow (-€7.9m).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Sep 24Agatos S.p.A. announced that it expects to receive €10 million in funding from Macquarie Group Limited, Investment Arm and other investorAgatos S.p.A. announced a private placement of convertible bonds for gross proceeds of up to €10,000,000 on September 22, 2022. The transaction will include participation from Macquarie Group Limited, Investment Arm, and ATLAS CAPITAL. The company has approved partial issuance of first tranche of convertible bond for up to €1,500,000.
Reported Earnings • Jun 18Full year 2021 earnings releasedFull year 2021 results: Net loss: €13.2m (loss widened 247% from FY 2020).
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 06First half 2021 earnings releasedThe company reported a soft first half result with increased losses and weaker control over costs, although revenues improved. First half 2021 results: Revenue: €1.93m (up 17% from 1H 2020). Net loss: €6.82m (loss widened 366% from 1H 2020).
Breakeven Date Change • Sep 23Forecast to breakeven in 2022The analyst covering Agatos expects the company to break even for the first time. New forecast suggests the company will make a profit of €1.72m in 2022. Average annual earnings growth of 99% is required to achieve expected profit on schedule.
공시 • Dec 30Sorgenia Sviluppo S.R.L. completed the acquisition of 75% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. (BIT:AGA) for €3.1 million.Sorgenia Sviluppo S.R.L. made a binding offer to acquire 80% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. (BIT:AGA) for €2.2 million on October 10, 2019. On December 17, 2020, Sorgenia Sviluppo S.R.L. signed agreement to acquire 75% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. Under the terms, the buyer will pay up to €0.2 million and will take up to 80% of Agatos's claims towards the project for up to €2 million. As of April 21, 2020, Agatos said that more time is needed to complete the transaction amid COVID-19 crisis. As of July 8, 2020, Agatos S.p.A. postpone the final terms of the deal to August 7, 2020. Closing is expected by year end 2020. Sorgenia Sviluppo S.R.L. completed the acquisition of 75% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. (BIT:AGA) for €3.1 million on December 28, 2020. The consideration includes €0.15 for Green Power Marcallese, €0.6 million for the debt owed by Green Power Marcallese to Agatos and assumed €2.3 million remaining creditor of Green Power Marcallese.
Is New 90 Day High Low • Nov 28New 90-day high: €1.04The company is up 3.0% from its price of €1.01 on 28 August 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Construction industry, which is up 9.0% over the same period.
Reported Earnings • Oct 04First half earnings releasedOver the last 12 months the company has reported total losses of €2.86m, with losses widening by 32% from the prior year. Total revenue was €3.84m over the last 12 months, down 41% from the prior year.
